Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangioma × Biopsy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 77 Neoplasm Metastasis 56 Prostatic Neoplasms 54 Leukemia, Myeloid, Acute 47 Melanoma 45 Multiple Myeloma 42 Lung Neoplasms 40 Colorectal Neoplasms 38 Carcinoma, Non-Small-Cell Lung 36 Pancreatic Neoplasms 33 Lymphoma 31 Neoplasms 27 Leukemia, Lymphocytic, Chronic, B-Cell 27 Squamous Cell Carcinoma of Head and Neck 26 Myelodysplastic Syndromes 24 Ovarian Neoplasms 23 Triple Negative Breast Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 22 Lymphoma, Follicular 19 Uterine Cervical Neoplasms 17 Sarcoma 17 Burkitt Lymphoma 17 Stomach Neoplasms 16 Carcinoma, Renal Cell 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Myeloproliferative Disorders 15 Leukemia, Myelomonocytic, Chronic 15 Head and Neck Neoplasms 15 Glioma 15 Fallopian Tube Neoplasms 15

Interventions

Propranolol 9 Timolol 5 Prednisolone 5 Prednisone 3 Adrenergic beta-Antagonists 3 Steroids 2 Solutions 2 Saline Solution 2 Methylprednisolone 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Urine Specimen Collection 1 Tomography, Optical Coherence 1 Therapeutics 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Observation 1 Nadolol 1 Mupirocin 1 Leuprolide 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 High-Energy Shock Waves 1 Hepatectomy 1 Gels 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02334930 2016-08-22

PEC-Hem

University Hospital, Bordeaux

Hemangioma, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡